The current valuation score of Altimmune Inc is 6.30, ranking 315 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.08, which is -54.71% below the recent high of -1.40 and -202.68% above the recent low of -9.32.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.